雑誌文献を検索します。書籍を検索する際には「書籍検索」を選択してください。

検索

書誌情報 詳細検索 by 医中誌

Japanese

Recent Advances in Novel Therapies for Neurological Diseases: An Overview and Future Scope Makoto Urushitani 1 1Department of Neurology, Shiga University of Medical Science Keyword: 神経疾患 , 抗体 , アンチセンスオリゴヌクレオチド , 酵素補充療法 , ドラッグリポジショニング , neurological disorders , antibody , antisense oligonucleotide , ASO , enzyme supplementation , drug-repositioning pp.411-417
Published Date 2023/5/1
DOI https://doi.org/10.11477/mf.1416202351
  • Abstract
  • Look Inside
  • Reference

Abstract

Disease-modifying therapies remain an important unmet medical need in many neurological diseases. However, recent advances in novel therapies, such as antisense oligonucleotides, antibodies, and enzyme supplementation have significantly improved the prognosis and delayed time until relapse of various neurological diseases. Nusinersen used for spinal muscular atrophy and patisiran for transthyretin-mediated familial amyloid polyneuropathy significantly suppress disease progression and prolong longevity. Antibodies against the CD antigen, interleukin, or complement significantly lessen the time until relapse of multiple sclerosis or neuromyelitis optica. Administration of antibodies has expanded for treatment of migraine and neurodegenerative diseases such as Alzheimer's disease. Therefore, a paradigm shift is being observed in therapeutic strategies for many neurological diseases, many of which are typically considered “intractable.”


Copyright © 2023, Igaku-Shoin Ltd. All rights reserved.

基本情報

電子版ISSN 1344-8129 印刷版ISSN 1881-6096 医学書院

関連文献

もっと見る

文献を共有